SBC Medical Participates in Upcoming Investor Conferences
News related to:SBC Medical Group Holdings Incorporated · 2 min read
IRVINE, Calif., Sept. 25, 2026 /CourierPR/ -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, announced its participation in several upcoming investor conferences in October 2026. The company will conduct presentations and one-on-one meetings with institutional investors at these events.
SBC Medical will be participating in the Noble Capital Markets October 2026 Emerging Growth Virtual Equity Conference, which will take place on October 1-2, 2026, in a virtual format. The Maxim Growth Summit 2026 will also see SBC Medical in attendance, scheduled for October 14, 2026, in an in-person format at New York City. Additionally, the company will be present at the ThinkEquity Conference 2026, which is set for October 15, 2026, also in an in-person format in New York City.
In September 2024, SBC Medical Group Holdings Incorporated was listed on the Nasdaq, marking a significant milestone in its journey. This listing provided the company with greater visibility and access to capital markets, allowing it to pursue further growth and expansion. In June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. This selection underscores the company's growing prominence and its commitment to providing safe, trusted, and high-quality medical services.
The company manages a diverse portfolio of clinic brands and is actively working to strengthen its international reputation for quality and trust in medical care.
The company's participation in these investor conferences underscores its commitment to engaging with institutional investors and stakeholders to discuss its growth prospects, strategic initiatives, and the company's continued focus on expanding its healthcare services. These conferences provide valuable opportunities for SBC Medical to share its achievements, address investor concerns, and outline its future plans, thereby fostering a deeper understanding and support from the investment community.
By participating in these conferences, SBC Medical aims to highlight its strategic initiatives, such as its focus on advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, Hair Loss treatment (AGA), and ophthalmology. The company's diverse portfolio of clinic brands and its active expansion into new markets, including the United States and Asia, are key factors in its growth strategy. Through these conferences, SBC Medical seeks to demonstrate its commitment to innovation and quality, thereby building a strong foundation for future success.
SBC Medical's participation in these investor conferences is a testament to its commitment to growth and its ongoing efforts to provide high-quality medical services. These events offer a platform for the company to engage with institutional investors, share its achievements, and outline its future plans, thereby fostering a deeper understanding and support from the investment community.